BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12819473)

  • 1. Autoimmunity in Wiskott-Aldrich syndrome.
    Schurman SH; Candotti F
    Curr Opin Rheumatol; 2003 Jul; 15(4):446-53. PubMed ID: 12819473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune manifestations of the Wiskott-Aldrich syndrome.
    Akman IO; Ostrov BE; Neudorf S
    Semin Arthritis Rheum; 1998 Feb; 27(4):218-25. PubMed ID: 9514127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases.
    Cleland SY; Siegel RM
    FEBS Lett; 2011 Dec; 585(23):3710-4. PubMed ID: 22036785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans.
    Castiello MC; Bosticardo M; Pala F; Catucci M; Chamberlain N; van Zelm MC; Driessen GJ; Pac M; Bernatowska E; Scaramuzza S; Aiuti A; Sauer AV; Traggiai E; Meffre E; Villa A; van der Burg M
    J Autoimmun; 2014 May; 50(100):42-50. PubMed ID: 24369837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical features of autoimmunity in 53 patients with Wiskott-Aldrich syndrome in China: a single-center study.
    Chen N; Zhang ZY; Liu DW; Liu W; Tang XM; Zhao XD
    Eur J Pediatr; 2015 Oct; 174(10):1311-8. PubMed ID: 25877044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
    Du HQ; Zhang X; An YF; Ding Y; Zhao XD
    Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
    Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
    J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosing cholangitis and intracranial lymphoma in a child with classical Wiskott-Aldrich syndrome.
    Vignesh P; Suri D; Rawat A; Lau YL; Bhatia A; Das A; Srinivasan A; Dhandapani S
    Pediatr Blood Cancer; 2017 Jan; 64(1):106-109. PubMed ID: 27566838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome.
    Khan S; Holding S; Doré PC; Sewell WA
    Med Hypotheses; 2008; 70(2):269-72. PubMed ID: 17664047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wiskott-Aldrich syndrome: new molecular and biochemical insights.
    Peacocke M; Siminovitch KA
    J Am Acad Dermatol; 1992 Oct; 27(4):507-19. PubMed ID: 1401301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets in Wiskott-Aldrich syndrome: Victims or executioners?
    Sereni L; Castiello MC; Villa A
    J Leukoc Biol; 2018 Mar; 103(3):577-590. PubMed ID: 28851742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells.
    Leverrier Y; Lorenzi R; Blundell MP; Brickell P; Kinnon C; Ridley AJ; Thrasher AJ
    J Immunol; 2001 Apr; 166(8):4831-4. PubMed ID: 11290758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of large granular lymphocyte subsets in Wiskott-Aldrich syndrome.
    Plebani A; Airò P; Brugnoni D; Lebowitz M; Cattaneo R; Monafo V; Meini A; Notarangelo LD; Duse M; Ugazio AG
    Haematologica; 1995; 80(6):521-5. PubMed ID: 8647517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wiskott-Aldrich syndrome].
    Gulácsy V; Maródi L
    Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome.
    Saurat JH
    Acta Derm Venereol Suppl (Stockh); 1985; 114():125-8. PubMed ID: 3890446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Wiskott--Aldrich syndrome a cell trafficking disorder?
    Thrasher AJ; Jones GE; Kinnon C; Brickell PM; Katz DR
    Immunol Today; 1998 Dec; 19(12):537-9. PubMed ID: 9864941
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved platelet function following bone marrow transplantation in an infant with the Wiskott-Aldrich syndrome.
    August CS; Hathaway WE; Githens JH; Pearlman D; McIntosh K; Favara B
    J Pediatr; 1973 Jan; 82(1):58-64. PubMed ID: 4564578
    [No Abstract]   [Full Text] [Related]  

  • 20. Wiskott-Aldrich syndrome caused by a new mutation associated with multifocal dermal juvenile xanthogranulomas.
    Jesenak M; Plamenova I; Plank L; Banovcin P
    Pediatr Dermatol; 2013; 30(5):e91-3. PubMed ID: 23157619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.